QIPT Stock Overview
Through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. More details
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Quipt Home Medical Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$3.57 |
52 Week High | CA$6.98 |
52 Week Low | CA$3.28 |
Beta | 1.0 |
1 Month Change | 5.93% |
3 Month Change | -3.77% |
1 Year Change | -47.35% |
3 Year Change | -49.58% |
5 Year Change | -5.05% |
Change since IPO | -18.86% |
Recent News & Updates
Recent updates
We Like These Underlying Return On Capital Trends At Quipt Home Medical (TSE:QIPT)
Dec 15Earnings Release: Here's Why Analysts Cut Their Quipt Home Medical Corp. (TSE:QIPT) Price Target To CA$10.95
Aug 17Is Quipt Home Medical (TSE:QIPT) A Risky Investment?
Aug 16Quipt Home Medical Corp.'s (TSE:QIPT) 26% Price Boost Is Out Of Tune With Revenues
Jul 26Returns At Quipt Home Medical (TSE:QIPT) Are On The Way Up
Jul 17Investors Aren't Entirely Convinced By Quipt Home Medical Corp.'s (TSE:QIPT) Revenues
Apr 19Quipt Home Medical Corp. (TSE:QIPT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
Feb 17What Is Quipt Home Medical Corp.'s (TSE:QIPT) Share Price Doing?
Sep 25Calculating The Fair Value Of Quipt Home Medical Corp. (TSE:QIPT)
Sep 01We Think Quipt Home Medical's (CVE:QIPT) Robust Earnings Are Conservative
Feb 21Earnings Update: Quipt Home Medical Corp. (CVE:QIPT) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts
Aug 18Health Check: How Prudently Does Quipt Home Medical (CVE:QIPT) Use Debt?
Jul 13When Should You Buy Quipt Home Medical Corp. (CVE:QIPT)?
Jun 08Quipt Home Medical Corp. (CVE:QIPT) Shares Could Be 43% Below Their Intrinsic Value Estimate
Jun 02Does Protech Home Medical (CVE:PTQ) Have A Healthy Balance Sheet?
May 07Protech Home Medical Corp. (CVE:PTQ) Could Be Less Than A Year Away From Profitability
Mar 29Can You Imagine How Elated Protech Home Medical's (CVE:PTQ) Shareholders Feel About Its 331% Share Price Gain?
Feb 22Calculating The Fair Value Of Protech Home Medical Corp. (CVE:PTQ)
Jan 18Shareholder Returns
QIPT | CA Healthcare | CA Market | |
---|---|---|---|
7D | -16.8% | -2.0% | -3.7% |
1Y | -47.3% | 33.3% | 15.0% |
Return vs Industry: QIPT underperformed the Canadian Healthcare industry which returned 33.3% over the past year.
Return vs Market: QIPT underperformed the Canadian Market which returned 15% over the past year.
Price Volatility
QIPT volatility | |
---|---|
QIPT Average Weekly Movement | 8.0% |
Healthcare Industry Average Movement | 4.2% |
Market Average Movement | 8.2% |
10% most volatile stocks in CA Market | 17.6% |
10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: QIPT has not had significant price volatility in the past 3 months compared to the Canadian market.
Volatility Over Time: QIPT's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 1,200 | Greg Crawford | quipthomemedical.com |
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers; invasive ventilation; and home medical equipment, such as stair lifts, ramps, bath safety equipment, daily living, and ambulatory, as well as home modification solutions. It also engages in the rental and sale of medical equipment and related devices.
Quipt Home Medical Corp. Fundamentals Summary
QIPT fundamental statistics | |
---|---|
Market cap | CA$149.96m |
Earnings (TTM) | -CA$9.71m |
Revenue (TTM) | CA$352.96m |
0.4x
P/S Ratio-15.8x
P/E RatioIs QIPT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
QIPT income statement (TTM) | |
---|---|
Revenue | US$245.92m |
Cost of Revenue | US$68.93m |
Gross Profit | US$176.99m |
Other Expenses | US$183.75m |
Earnings | -US$6.76m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.16 |
Gross Margin | 71.97% |
Net Profit Margin | -2.75% |
Debt/Equity Ratio | 76.3% |
How did QIPT perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/20 22:56 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2024/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Quipt Home Medical Corp. is covered by 11 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Ishan Majumdar | Baptista Research |
Doug Cooper | Beacon Securities Limited |
William Sutherland | Benchmark Company |